News

The company has been streamlining and refining its operations over the past 18 months. In the final stage of the process carried out recently, the number of staff

Protect is powered to detect a clinically significant difference in rates of stent thrombosis between the two devices. Protect’s primary endpoint is overall stent thrombosis at three years;

The studies showed that ADX48621, a metabotropic glutamate receptor 5 negative allosteric modulator in development for Parkinson’s disease levodopa induced dyskinesia (PD-LID), is safe and well-tolerated in healthy

Under the terms of the agreement, Church & Dwight acquired exclusive world-wide rights to use certain QuantRx technology related to a jointly developed at-home diagnostic test for the

Dr Ashton joined pSivida in December 2005 following the acquisition of Control Delivery Systems where he was co-founder, president, CEO, and a member of the board of directors.

Mr Lefaivre was the vice president of consulting and strategic development for Brogan, a healthcare market research company, and previously served as vice president of strategy and business

According to the company, CryoSolve contains all organic raw materials – serum-free/animal-free, packaged in single-use syringes filled with ready-for-use media. Syringes have Luer-lock tips to help ease the

Toshiba Medical said that this acquisition brings in-house the development of 3D volume rendering and advanced visualization capabilities for all its modalities. The advanced visualization imaging system (AVIS)

The new corporate headquarters, located in Columbia, South Carolina, serves as the primary distribution center and provides more than threefold the office space and warehousing capabilities of the